| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 06/08/2005 | EP1432427B1 Composition of hypochlorous acid and its applications |
| 06/08/2005 | EP1414937B1 Hops extracts, method for the production and use |
| 06/08/2005 | EP1373269B1 Jun kinase inhibitors |
| 06/08/2005 | EP1337526B1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 06/08/2005 | EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | CN1625603A Genetic polymorphisms in the preprotachykinin gene |
| 06/08/2005 | CN1625566A Lactoferrin |
| 06/08/2005 | CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/08/2005 | CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| 06/08/2005 | CN1623592A Preparation of preventing osteoporosis and delaying senility and its preparation process |
| 06/08/2005 | CN1623588A Chinese medicinal composition for treating bone fracture and soft tissue injury |
| 06/08/2005 | CN1623585A Skeleton glue and its preparation method |
| 06/08/2005 | CN1623584A Aerosol for treating knochs and falls and its preparation method |
| 06/08/2005 | CN1623571A Traditional Chinese medicine for treating neck disease |
| 06/08/2005 | CN1623570A External-use traditional Chinese medicine for treating arthropathy hyperosteogeny |
| 06/08/2005 | CN1623569A Traditional Chinese medicine for treeting gonarthrosis |
| 06/08/2005 | CN1623568A Traditional Chinese medicine for treating hyperosteogeny and protrusion of interverteral disc |
| 06/08/2005 | CN1623547A Medical use of artificial lywrine |
| 06/08/2005 | CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide |
| 06/08/2005 | CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/08/2005 | CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex. |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903089 Lactam-substituted pyrazolopyridine derivatives |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6903079 Nucleoside compounds and compositions thereof |
| 06/07/2005 | US6902748 Medicines manufactured from old platycodon extracts |
| 06/07/2005 | US6902739 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/02/2005 | WO2005005606A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | WO2005005380A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | WO2003087375A8 Cartilage differentiation regulating gene |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | US20050119499 Cyclic hemiacetal derivative and use thereof |
| 06/02/2005 | US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 06/02/2005 | US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119291 Pyrimidine compounds |
| 06/02/2005 | US20050119290 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 06/02/2005 | US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| 06/02/2005 | US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119240 1-methyl-20-epi-vitamin d derivative |
| 06/02/2005 | US20050119216 Pharmaceutical compositions and methods relating to fucans |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119204 Osteopontin-related compositions and methods |
| 06/02/2005 | US20050118696 Methods and means for modulating PGE synthase activity |
| 06/02/2005 | US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 06/02/2005 | US20050118242 Using testosterone; topical applying to skins |
| 06/02/2005 | US20050118232 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 06/02/2005 | US20050118190 Staphylococcus antigen and vaccine |
| 06/02/2005 | US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 06/02/2005 | US20050118157 Treatment of central nervous system damage |
| 06/02/2005 | CA2546028A1 Novel compounds |
| 06/02/2005 | CA2545912A1 Autologous treatment of degenerated disc with cells |
| 06/02/2005 | CA2545723A1 Use of cathepsin k inhibitors in severe bone loss diseases |
| 06/01/2005 | EP1536012A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1535910A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1535907A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 06/01/2005 | EP1534731A1 Bmp-2 estrogen responsive element and methods of using the same |
| 06/01/2005 | EP1534725A2 Compounds and methods for inhibiting selectin-mediated function |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534681A1 Substituted quinoline ccr5 receptor antagonists |
| 06/01/2005 | EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534331A2 Membrane associated tumor endothelium markers |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534305A2 Treating cartilage / bone conditions with water-soluble strontium salts |
| 06/01/2005 | EP1534302A2 Arginine silicate inositol complex and use thereof |
| 06/01/2005 | EP1534292A2 Protease inhibitors |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534281A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534274A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib |
| 06/01/2005 | EP1534265A1 Combination of an aromatase inhibitor with a bisphosphonate |
| 06/01/2005 | EP1534260A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |